Skip to main content
. Author manuscript; available in PMC: 2024 Jun 2.
Published in final edited form as: Nanoscale Horiz. 2022 Dec 20;8(1):10–28. doi: 10.1039/d2nh00289b

figure 4.

figure 4.

delivery of mrna for macrophage polarization and synergistic immunotherapy. a) schematic representation of mrna/lnp. b,c) mrna expression of classic m1 (b) and m2 (c) markers in hcc tumor tissues 48 h after systemic administration of mrna/lnp. d) percentage of cd8+ t cells in cd3+ t cells. e) percentage of nk cells in cd45+cd3- cells. immune cells derived from mice 48 h after injection with mrna/lnp.